HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhigang Wang Selected Research

perflubron (L 1913)

1/2021Combination Nanotherapeutics for Dry Eye Disease Treatment in a Rabbit Model.
1/2019NIR-responsive nanoplatform for pre/intraoperative image-guided carcinoma surgery and photothermal ablation of residual tumor tissue.
8/2018Mitochondria-Targeted Artificial "Nano-RBCs" for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation.
1/2018Perfluorooctyl bromide & indocyanine green co-loaded nanoliposomes for enhanced multimodal imaging-guided phototherapy.
12/2017Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model.
1/2015Synthesis and evaluation of perfluorooctylbromide nanoparticles modified with a folate receptor for targeting ovarian cancer: in vitro and in vivo experiments.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhigang Wang Research Topics

Disease

221Neoplasms (Cancer)
11/2022 - 06/2002
30Inflammation (Inflammations)
10/2022 - 07/2011
27Neoplasm Metastasis (Metastasis)
01/2022 - 07/2008
26Breast Neoplasms (Breast Cancer)
01/2022 - 04/2010
21Ovarian Neoplasms (Ovarian Cancer)
10/2021 - 01/2013
17Hypoxia (Hypoxemia)
01/2022 - 06/2008
15Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 03/2008
15Lung Neoplasms (Lung Cancer)
12/2021 - 01/2013
14Infections
01/2021 - 12/2002
14Hepatocellular Carcinoma (Hepatoma)
01/2021 - 12/2010
12Necrosis
01/2021 - 12/2002
10Thrombosis (Thrombus)
04/2022 - 01/2013
10Hyperthermia
01/2021 - 06/2012
9Glioma (Gliomas)
01/2021 - 04/2015
8Osteosarcoma (Osteogenic Sarcoma)
06/2022 - 06/2013
8Stomach Neoplasms (Stomach Cancer)
12/2021 - 01/2012
7Carcinogenesis
01/2022 - 07/2008
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2020 - 06/2002
6Fibrosis (Cirrhosis)
05/2022 - 05/2010
6Reperfusion Injury
01/2022 - 01/2014
6Melanoma (Melanoma, Malignant)
06/2020 - 06/2014
6Carcinoma (Carcinomatosis)
01/2017 - 07/2008
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 07/2002
5Obesity
01/2022 - 02/2012
5Acute Kidney Injury (Acute Renal Failure)
01/2021 - 01/2018
5Body Weight (Weight, Body)
11/2020 - 11/2010
5Hypersensitivity (Allergy)
06/2020 - 02/2017
5Ischemia
01/2016 - 03/2006
5Myocardial Infarction
09/2013 - 03/2008
4Adenocarcinoma
10/2022 - 05/2016
4COVID-19
03/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

52Pharmaceutical PreparationsIBA
07/2022 - 11/2010
37Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
29Therapeutic UsesIBA
05/2022 - 11/2010
21Contrast MediaIBA
11/2022 - 06/2012
18Oxygen (Dioxygen)IBA
03/2022 - 05/2015
18Folic Acid (Vitamin M)FDA LinkGeneric
01/2021 - 12/2011
16MicroRNAs (MicroRNA)IBA
10/2021 - 01/2012
14Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 01/2016
14LipidsIBA
01/2022 - 01/2010
13Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2002
13Cisplatin (Platino)FDA LinkGeneric
01/2021 - 08/2014
11Peptides (Polypeptides)IBA
01/2022 - 01/2012
11ProdrugsIBA
01/2022 - 08/2014
11DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2002
10Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2013
10Paclitaxel (Taxol)FDA LinkGeneric
07/2021 - 01/2014
10CytokinesIBA
01/2021 - 01/2016
10Messenger RNA (mRNA)IBA
11/2020 - 04/2010
10LigandsIBA
06/2020 - 01/2013
91-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2022 - 01/2018
9Liposomes (Liposome)IBA
05/2022 - 01/2017
9PlatinumIBA
01/2022 - 01/2014
9Polylactic Acid-Polyglycolic Acid CopolymerIBA
03/2021 - 08/2012
8Glucose (Dextrose)FDA LinkGeneric
11/2022 - 05/2010
8Long Noncoding RNAIBA
05/2022 - 04/2015
8Biological ProductsIBA
01/2021 - 08/2012
8FluorocarbonsIBA
01/2021 - 01/2014
8Small Interfering RNA (siRNA)IBA
06/2020 - 04/2010
7AntigensIBA
12/2022 - 01/2012
7Caspase 3 (Caspase-3)IBA
01/2022 - 01/2017
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 01/2013
7Indocyanine Green (Cardio-Green)FDA LinkGeneric
04/2020 - 05/2015
6Phosphotransferases (Kinase)IBA
10/2022 - 11/2010
6Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
6AntioxidantsIBA
01/2022 - 02/2017
6Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2021 - 02/2017
6PolymersIBA
01/2021 - 10/2012
6perflubron (L 1913)FDA Link
01/2021 - 01/2015
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 03/2006
6ferric oxide (iron oxide)IBA
01/2017 - 08/2012
5IronIBA
03/2022 - 10/2018
5Photosensitizing Agents (Photosensitizers)IBA
02/2022 - 02/2020
5Indicators and Reagents (Reagents)IBA
01/2022 - 07/2012
5CreatinineIBA
10/2021 - 05/2020
5perfluoropentane (perflenapent)IBA
09/2021 - 01/2017
5homocamptothecinIBA
01/2021 - 09/2012
5perflexane (perfluorohexane)FDA Link
09/2020 - 08/2013
5GoldIBA
01/2020 - 10/2016
5Arachidonic Acid (Vitamin F)IBA
11/2013 - 06/2008
4Blood Glucose (Blood Sugar)IBA
01/2022 - 12/2014
4Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 08/2011
4TeaIBA
01/2022 - 07/2002
4Sevoflurane (Ultane)FDA LinkGeneric
01/2022 - 09/2013
4hydroxide ionIBA
01/2022 - 08/2014

Therapy/Procedure

125Therapeutics
11/2022 - 04/2010
45Drug Therapy (Chemotherapy)
11/2021 - 01/2010
42Precision Medicine
03/2022 - 03/2013
32Microbubbles
01/2021 - 03/2008
19Photothermal Therapy
01/2022 - 01/2017
18Lasers (Laser)
01/2022 - 01/2014
11Immunotherapy
01/2022 - 01/2016
9Photochemotherapy (Photodynamic Therapy)
02/2022 - 01/2017
8Transplantation
07/2021 - 12/2010
7Injections
01/2021 - 02/2012
7Phototherapy (Light Therapy)
01/2021 - 01/2018
6Aftercare (After-Treatment)
08/2021 - 12/2014
5Acupuncture Points (Acupuncture Point)
01/2022 - 04/2017
5Stents
11/2020 - 10/2013
4Electroacupuncture
01/2022 - 10/2019